Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia
Tóm tắt
Serum levels of interleukin-1 beta (IL-1β), soluble interleukin 2 receptors (sIL-2R), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-α) were measured to predict some characteristics of febrile episodes in children with cancer and neutropenia. Forty-eight episodes of febrile neutropenia were determined in 23 pediatric cancer patients, including 35 febrile episodes without identifiable source, 7 episodes of bacteremia due to Gram-negative organisms and 4 due to Gram-positive organisms, and 2 fungal infections. Interleukin-6, sIL-2R, and IL-8 levels were significantly higher at the beginning of the febrile episodes than those of controls (p<0.001, p<0.001, and p<0.001). Interleukin-6, sIL-2R, and IL-8 levels were higher in patients with bacteremia due to Gram-negative organisms than in those with Gram-positive ones (p=0.042, p=0.006, and p=0.023, respectively). TNF-α and IL-1β levels were similar in febrile episodes and controls (p>0.05). In conclusion, sIL-2R, IL-6, and IL-8 levels may be helpful in the prediction of infection in febrile cancer patients with neutropenia and measurements of IL-1β and TNF-α were not useful for identifying the presence and the type of infection in febrile neutropenic episodes in children.
Tài liệu tham khảo
Pizzo, P.A. (1993). Management of fever in patients with cancer and treatment-induced neutropenia. New Engl. J. Med. 328:1323–1332.
Schonbohn, H. et al. (1995). Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia. Ann. Hematol. 71:161–168.
Raziuddin, S., Sheikha, A., Abu-Eshy, S., al-Janadi, M. (1994). Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies. Cancer 73:2426–2431.
Waage, A., Steinshamn, S. (1993). Cytokine mediators in septic infections in the normal and granulocytopenic host. Eur J Haematol 50:243–249.
Lehrnbecher, T., Venzon, D., de Haas, M., Chanock, S.J., Kuhl, J. (1999). Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin. Infect. Dis. 29:414–419.
Lehmbecher, T., Foster, C., Vazquez, N., Mackall, C.L., Chanock, S.J. (1997). Therapy induced alterations in host defense in children receiving chemotherapy. J. Pediatr. Hematol. Oncol. 19:399–417.
Mackall, C. et al. (1994). Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84:2221–2228.
Miethke, T. et al. (1992). T cell-mediated lethal schock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:91–98.
Schumann, R.R. (1992). Function of LPS-binding protein and CD-14, the receptor for LPS/LBP complexes: a short review. Rem. Immunol. 143:11–15.
Engervall, P., Andersson, B., Bjorkholm, M. (1995). Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia. Br. J. Haematol. 91:838–845.
Engel, A., Kern, W.V., Murdter, G., Kern., P. (1994). Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia. Infection 22:160–164.
Fong, Y., Lowry, S.F. (1990). Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin. Immunol. Immunopathol. 55:157–170.
Hack, C.E. et al. (1992). Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect. Immun. 60:2835–2842.
Dinarello, C.A., Wolff, S.M. (1992). The role of interleukin-1 in disease. New. Engl. J. Med. 328:106–113.
Parillo, J.E. (1993). Pathogenetic mechanisms of septic shock. New Engl. J. Med. 328:1471–1477.
Waage, A., Remick, D., Steinshamn, S., Deforge, L., Lamvik, J. (1994). Interleukin 8 in serum in granulocytopenic patients with infections. Br J Haematol 86:36–40.